“The maker of Gaviscon indigestion medicine is alleged to have removed one version of the drug from NHS lists to encourage doctors to prescribe a more expensive variety. The Office of Fair Trading said yesterday that Reckitt Benckiser had abused its bestselling position in the market for supplying heartburn medicines to the NHS.”
The Times, 24th February 2010
Source: www.timesonline.co.uk
